BRCA population screening for predicting breast cancer: for or against?

Main|Search|PHGKB






Last Posted: Aug 05, 2017

---

• BRCA population screening for predicting breast cancer: for or against?  
  G Lippi et al, Ann Trans Med, July 2017
• "I've just never gotten around to doing it": Men's approaches to managing BRCA-related cancer risks.  
  Rauscher Emily A et al. Patient education and counseling 2017 Jul
• FDA Approval Summary: Rucaparib for the treatment of patients with deleterious BRCA mutation-associated advanced ovarian cancer.  
  Balasubramaniam Sanjeeve et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Jul
• The risk of unjustified BRCA testing after the "Angelina Jolie effect": how can we save (laboratory) medicine from the Internet?  
  Lippi Giuseppe et al. Clinical chemistry and laboratory medicine 2017 Jul
• A comparative study of germline BRCA1 and BRCA2 mutation screening methods in use in 20 European clinical diagnostic laboratories.  
  Ellison Gillian et al. British journal of cancer 2017 Jul
• Genetic Counselling, BRCA1/2 Status and Clinico-pathologic Characteristics of Patients with Ovarian Cancer before 50 Years of Age.  
  Cvelbar Mirjam et al. Radiology and oncology 2017 Jun 51(2) 187-194
• High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.  
  Sanford Rachel A et al. Cancer 2015 Oct 121(19) 3422-7
• I wish we'd known sooner about BRCA gene mutations  
  BC Selling, blog post, Ovarian Cancer UK, 2017
• Innovative practice model to optimize resource utilization and improve access to care for high-risk and BRCA+ patients.  
  Head Linden et al. Canadian journal of surgery. Journal canadien de chirurgie 2017 Feb 60(1) 37-44
• Why I Asked My Mom to Undergo Genetic Testing After Her Ovarian Cancer Diagnosis  
  L Rezende, FORCE blog post, July 25, 2017
• Data sharing as a national quality improvement program: reporting on BRCA1 and BRCA2 variant-interpretation comparisons through the Canadian Open Genetics Repository (COGR).  
  Lebo Matthew S et al. Genetics in medicine : official journal of the American College of Medical Genetics 2017 Jul
• Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women  
  T Walsh et al, JAMA Oncology, July 20, 2017
• Study sheds light on the 'other' breast cancer genes  
  J Howard, CNN, July 21, 2017
• Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer.  
  Gamble Charlotte et al. Annals of surgical oncology 2017 Jul
• Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.  
  Manchanda Ranjit et al. American journal of obstetrics and gynecology 2017 Jul
• Large Study Verifies Cancer Risk for Women Carrying BRCA1 or BRCA2 Mutations  
  NCI, July 112, 2017

more